Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Däumer

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|August 24, 2007
Trends of prevalence of primary HIV drug resistance in GermanyAbdurrahman Sagir, Mark Oette, Rolf Kaiser, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testingMark Oette, Rolf Kaiser, Martin Däumer, et al.
AIDS Research and Human Retroviruses|March 26, 2010
Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G sourceMartin Däumer, Sabine Awerkiew, Saleta Sierra Aragón, et al.
Nucleic Acids Research|May 3, 2018
geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing dataMatthias Döring, Joachim Büch, Georg Friedrich, et al.
Journal of Visualized Experiments : Jove|December 14, 2011
Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approachSaleta Sierra, Rolf Kaiser, Nadine Lübke, et al.
Antiviral Therapy|November 21, 2007
Predicting HIV coreceptor usage on the basis of genetic and clinical covariatesTobias Sing, Andrew J Low, Niko Beerenwinkel, et al.
Clinical and Vaccine Immunology : CVI|August 24, 2007
Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population levelGolo Ahlenstiel, Kirsten Roomp, Martin Däumer, et al.
Journal of Clinical Microbiology|August 3, 2018
Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTi<i>m</i>e HIV-1 Reference AssayFrank Wiesmann, Robert Ehret, Gudrun Naeth, et al.
Retrovirology|January 7, 2018
Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistanceAxel Fun, Thomas Leitner, Linos Vandekerckhove, et al.
The Journal of Infectious Diseases|February 26, 2009
Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical databaseAndré Altmann, Martin Däumer, Niko Beerenwinkel, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|August 24, 2007
Trends of prevalence of primary HIV drug resistance in GermanyAbdurrahman Sagir, Mark Oette, Rolf Kaiser, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2006
Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testingMark Oette, Rolf Kaiser, Martin Däumer, et al.
AIDS Research and Human Retroviruses|March 26, 2010
Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G sourceMartin Däumer, Sabine Awerkiew, Saleta Sierra Aragón, et al.
Nucleic Acids Research|May 3, 2018
geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing dataMatthias Döring, Joachim Büch, Georg Friedrich, et al.
Journal of Visualized Experiments : Jove|December 14, 2011
Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approachSaleta Sierra, Rolf Kaiser, Nadine Lübke, et al.
Antiviral Therapy|November 21, 2007
Predicting HIV coreceptor usage on the basis of genetic and clinical covariatesTobias Sing, Andrew J Low, Niko Beerenwinkel, et al.
Clinical and Vaccine Immunology : CVI|August 24, 2007
Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population levelGolo Ahlenstiel, Kirsten Roomp, Martin Däumer, et al.
Journal of Clinical Microbiology|August 3, 2018
Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTi<i>m</i>e HIV-1 Reference AssayFrank Wiesmann, Robert Ehret, Gudrun Naeth, et al.
Retrovirology|January 7, 2018
Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistanceAxel Fun, Thomas Leitner, Linos Vandekerckhove, et al.
The Journal of Infectious Diseases|February 26, 2009
Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical databaseAndré Altmann, Martin Däumer, Niko Beerenwinkel, et al.
Pageof 6